We are pleased to announce that the ACVM in New Zealand has approved registration for Arthramid Vet.

New Zealand is the first country in the world and sets a precedent for other jurisdictions. Registration is an intensive technical appraisal including chemistry, manufacturing, efficacy, and toxicology.

Prev Post
Previous
Next Post
Up next